HR 447
116th Congress
House
Health
Administrative law and regulatory procedures
Canada
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Prescription drugs
Trade restrictions
User charges and fees
Affordable and Safe Prescription Drug Importation Act
Introduced: January 10, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 25, 2019
Referred to the Subcommittee on Health.
Jan 10, 2019
Referred to the House Committee on Energy and Commerce.
Jan 10, 2019
Introduced in House
Plain-English summary
Affordable and Safe Prescription Drug Importation Act
This bill addresses the importation of drugs from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries.
The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2